SP 15D2

SPECIAL FORM 10-K

Company: Phio Pharmaceuticals Corp.
Filed: May 8, 2012
Period of Report: December 31, 2011
Accession Number: 0000950123-12-008058

View Document ↗ View on SEC.gov ↗